from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1739c/-

LFCtreatmentdescriptionclass of inhibitor

-0.367

Amikacinug/mL Amikacintranslation

0.682

Cap5-10ug/mL Capreomycintranslation

-0.176

Rox10-50 ug/mL Roxithromycintranslation

-0.340

SM2-5 ug/mL Streptomycintranslation

-0.993

Tet5-10 ug/mL Tetracyclinetranslation

-0.100

Rif0.2-5ug/mL Rifampicintranscription

0.086

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.165

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.881

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.279

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.684

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.157

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.367

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.601

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.356

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.860

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.591

Nigericin50 uM Nigericinrespiration

0.298

TRC10-150 ug/mL Triclosanrespiration

1.542

TRZ10-25 ug/mL Thioridazinerespiration

-0.917

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.218

menadione6-10 ug/mL Menadionerespiration

-0.121

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.338

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.510

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.694

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.145

NRP_1Non-replicating persistence stage 1dosRassociated

-0.587

Amp0.2mg/mL AmpicillincellWall

0.805

Cephalexin20-100 ug/mL CephalexincellWall

2.584

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.476

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.125

EMB10-20 ug/mL EthambutolcellWall

-0.085

Eta12-40 ug/mL EthionamidecellWall

-0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.162

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.390

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.183

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.499

BZA0.12 mg/mL BenzamidearomaticAmides

-0.512

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.113

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.181

H2O24 mM hydrogen peroxideDNAdamaging

0.083

Levo10 ug/mL LevofloxacinDNAdamaging

-0.331

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.345

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.303

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.324

UVUV-irradiationDNAdamaging

0.996

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.540

Antimycin12.5-50 ug/mL Antimycin A?

-1.393

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.485

PA_110-50 ug/mL Antitubercular compound PA-1?

2.117

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.013

PA8240.2-2 ug/mL PA-824?

0.052

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.609

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.884

Verapamil50 uM Verapamil?

1.437

mercaptoethanol2 mM 2-Mercaptoethanol?

0.724

methoxatin10-20 ug/mL Methoxatin?